Catherine L Smith

US Patent:

20140023730, Jan 23, 2014

Filed:

Oct 1, 2013

Appl. No.:

14/042783

Inventors:

Anthony James Lepine - Greendale WI, US
Catherine Marie Smith - Grafton WI, US
Kevin Robert Wirtz - Belgium WI, US
Erich Schulze - Mission Viejo CA, US

Assignee:

Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals - Scottsdale AZ

International Classification:

A61K 33/00

US Classification:

424718

Abstract:

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

US Patent:

48681326, Sep 19, 1989

Filed:

Feb 3, 1987

Appl. No.:

7/010355

Inventors:

Paul J. Byrnes - Libertyville IL
Cynthia M. Molina - Northbrook IL
Janis A. Martinus - Wildwood IL
Kenward S. Vaughan - Carlsbad CA
Catherine M. Smith - Carlsbad CA

Assignee:

Abbott Laboratories - North Chicago IL

International Classification:

G01N 33533

US Classification:

436546

Abstract:

This disclosure relates to a method and reagents for determining amphetamine and methamphetamine in a biological fluid such as urine. In particular, this disclosure relates to a fluorescence polarization immunoassay procedure for determining the presence of amphetamine and methamphetamine in a single assay and to a novel class of tracer compounds employed as reagents in such procedures. The procedure described includes pretreatment of the biological sample to eliminate cross-reactants such as. beta. -hydroxyphenethylamine by preincubating the sample solely with an aqueous periodate solution having a pH from about 4. 0 to about 7. 5 without adjustment to an alkaline pH.

US Patent:

49523368, Aug 28, 1990

Filed:

Jul 22, 1989

Appl. No.:

7/223193

Inventors:

Paul J. Brynes - Libertyville IL
Cynthia M. Molina - Northbrook IL
Janis A. Martinus - Wildwood IL
Kenward S. Vaughan - Carlsbad CA
Catherine M. Smith - Carlsbad CA

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

C09K 1106

US Classification:

25230116

Abstract:

This disclosure relates to a method and reagents for determining amphetamine and methamphetamine in a biological fluid such as urine. In particular, this disclosure relates to a fluorescence polarization immunoassay procedure for determining the presence of amphetamine and methamphetamine in a single assay and to a novel class of tracer compounds employed as reagents in such procedures. The procedure described includes pretreatment of the biological sample to eliminate cross-reactants such as. beta. -hydroxyphenethylamine by preincubating the sample solely with an aqueous periodate solution having a pH from about 4. 0 to about 7. 5 without adjustment to an alkaline pH.

US Patent:

20210100833, Apr 8, 2021

Filed:

Dec 18, 2020

Appl. No.:

17/126329

Inventors:

- Scottsdale AZ, US
Anthony James Lepine - Greendale WI, US
Catherine Marie Smith - Grafton WI, US
Kevin Robert Wirtz - Belgium WI, US
Erich Schulze - Mission Viejo CA, US

International Classification:

A61K 33/00
C01B 21/50
A61P 17/00
A61P 9/00
A61P 43/00
A61P 11/00
A61K 31/17
A61K 31/4418
A61K 31/4709
A61K 31/519
A61K 9/08
A61K 9/00

Abstract:

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

US Patent:

20200237809, Jul 30, 2020

Filed:

Apr 8, 2020

Appl. No.:

16/842939

Inventors:

- Scottsdale AZ, US
Anthony James Lepine - Greendale WI, US
Catherine Marie Smith - Grafton WI, US
Kevin Robert Wirtz - Belgium WI, US
Erich Schulze - Mission Viejo CA, US

International Classification:

A61K 33/00
A61P 11/00
A61P 43/00
A61P 9/00
A61P 17/00
A61K 9/00
A61K 9/08
A61K 31/519
A61K 31/4709
A61K 31/4418
A61K 31/17
C01B 21/50

Abstract:

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

US Patent:

20200016193, Jan 16, 2020

Filed:

Sep 23, 2019

Appl. No.:

16/578671

Inventors:

- Scottsdale AZ, US
Anthony James Lepine - Greendale WI, US
Catherine Marie Smith - Grafton WI, US
Kevin Robert Wirtz - Belgium WI, US
Erich Schulze - Mission Viejo CA, US

International Classification:

A61K 33/00
A61K 9/00
A61K 9/08
A61K 31/519
A61K 31/4709
A61K 31/4418
A61K 31/17
C01B 21/50

Abstract:

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

US Patent:

20180256638, Sep 13, 2018

Filed:

May 8, 2018

Appl. No.:

15/973659

Inventors:

- Scottsdale AZ, US
Anthony James Lepine - Greendale WI, US
Catherine Marie Smith - Grafton WI, US
Kevin Robert Wirtz - Belgium WI, US
Erich Schulze - Mission Viejo CA, US

International Classification:

A61K 33/00
A61K 31/4709
A61K 9/08
A61K 31/519
A61K 31/4418
A61K 31/17
C01B 21/50
A61K 9/00

Abstract:

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

US Patent:

20170252368, Sep 7, 2017

Filed:

May 19, 2017

Appl. No.:

15/599617

Inventors:

- Scottsdale AZ, US
Anthony James Lepine - Greendale WI, US
Catherine Marie Smith - Grafton WI, US
Kevin Robert Wirtz - Belgium WI, US
Erich Schulze - Mission Viejo CA, US

International Classification:

A61K 33/00
A61K 31/17
A61K 31/4709
A61K 9/00
A61K 31/519
A61K 9/08
C01B 21/50
A61K 31/4418

Abstract:

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.